Literature DB >> 35896340

Ornithine Decarboxylase in Gastric Epithelial Cells Promotes the Immunopathogenesis of Helicobacter pylori Infection.

Yvonne L Latour1,2, Johanna C Sierra1,3, Kara M McNamara1,4, Thaddeus M Smith1, Paula B Luis5, Claus Schneider5, Alberto G Delgado1, Daniel P Barry1, Margaret M Allaman1, M Wade Calcutt6, Kevin L Schey6, M Blanca Piazuelo1,3, Alain P Gobert1,3, Keith T Wilson7,2,3,4,8.   

Abstract

Colonization by Helicobacter pylori is associated with gastric diseases, ranging from superficial gastritis to more severe pathologies, including intestinal metaplasia and adenocarcinoma. The interplay of the host response and the pathogen affect the outcome of disease. One major component of the mucosal response to H. pylori is the activation of a strong but inefficient immune response that fails to control the infection and frequently causes tissue damage. We have shown that polyamines can regulate H. pylori-induced inflammation. Chemical inhibition of ornithine decarboxylase (ODC), which generates the polyamine putrescine from l-ornithine, reduces gastritis in mice and adenocarcinoma incidence in gerbils infected with H. pylori However, we have also demonstrated that Odc deletion in myeloid cells enhances M1 macrophage activation and gastritis. Here we used a genetic approach to assess the specific role of gastric epithelial ODC during H. pylori infection. Specific deletion of the gene encoding for ODC in gastric epithelial cells reduces gastritis, attenuates epithelial proliferation, alters the metabolome, and downregulates the expression of immune mediators induced by H. pylori Inhibition of ODC activity or ODC knockdown in human gastric epithelial cells dampens H. pylori-induced NF-κB activation, CXCL8 mRNA expression, and IL-8 production. Chronic inflammation is a major risk factor for the progression to more severe pathologies associated with H. pylori infection, and we now show that epithelial ODC plays an important role in mediating this inflammatory response.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35896340      PMCID: PMC9378675          DOI: 10.4049/jimmunol.2100795

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  47 in total

1.  α-Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in Helicobacter pylori cagY.

Authors:  Johanna C Sierra; Giovanni Suarez; M Blanca Piazuelo; Paula B Luis; Dara R Baker; Judith Romero-Gallo; Daniel P Barry; Claus Schneider; Douglas R Morgan; Richard M Peek; Alain P Gobert; Keith T Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-25       Impact factor: 11.205

Review 2.  Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.

Authors:  Miguel Areia; Rita Carvalho; Ana Teresa Cadime; Francisco Rocha Gonçalves; Mário Dinis-Ribeiro
Journal:  Helicobacter       Date:  2013-04-09       Impact factor: 5.753

3.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

4.  APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse.

Authors:  S H Erdman; N A Ignatenko; M B Powell; K A Blohm-Mangone; H Holubec; J M Guillén-Rodriguez; E W Gerner
Journal:  Carcinogenesis       Date:  1999-09       Impact factor: 4.944

5.  High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation.

Authors:  C A Hobbs; S K Gilmour
Journal:  J Cell Biochem       Date:  2000-04       Impact factor: 4.429

6.  Induction of autophagy by spermidine promotes longevity.

Authors:  Tobias Eisenberg; Heide Knauer; Alexandra Schauer; Sabrina Büttner; Christoph Ruckenstuhl; Didac Carmona-Gutierrez; Julia Ring; Sabrina Schroeder; Christoph Magnes; Lucia Antonacci; Heike Fussi; Luiza Deszcz; Regina Hartl; Elisabeth Schraml; Alfredo Criollo; Evgenia Megalou; Daniela Weiskopf; Peter Laun; Gino Heeren; Michael Breitenbach; Beatrix Grubeck-Loebenstein; Eva Herker; Birthe Fahrenkrog; Kai-Uwe Fröhlich; Frank Sinner; Nektarios Tavernarakis; Nadege Minois; Guido Kroemer; Frank Madeo
Journal:  Nat Cell Biol       Date:  2009-10-04       Impact factor: 28.824

7.  A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.

Authors:  Giselle L Saulnier Sholler; Eugene W Gerner; Genevieve Bergendahl; Robert B MacArthur; Alyssa VanderWerff; Takamaru Ashikaga; Jeffrey P Bond; William Ferguson; William Roberts; Randal K Wada; Don Eslin; Jacqueline M Kraveka; Joel Kaplan; Deanna Mitchell; Nehal S Parikh; Kathleen Neville; Leonard Sender; Timothy Higgins; Masao Kawakita; Kyoko Hiramatsu; Shun-Suke Moriya; André S Bachmann
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

8.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  Distinct Immunomodulatory Effects of Spermine Oxidase in Colitis Induced by Epithelial Injury or Infection.

Authors:  Alain P Gobert; Nicole T Al-Greene; Kshipra Singh; Lori A Coburn; Johanna C Sierra; Thomas G Verriere; Paula B Luis; Claus Schneider; Mohammad Asim; Margaret M Allaman; Daniel P Barry; John L Cleveland; Christina E Destefano Shields; Robert A Casero; M Kay Washington; M Blanca Piazuelo; Keith T Wilson
Journal:  Front Immunol       Date:  2018-06-05       Impact factor: 7.561

10.  Tximeta: Reference sequence checksums for provenance identification in RNA-seq.

Authors:  Michael I Love; Charlotte Soneson; Peter F Hickey; Lisa K Johnson; N Tessa Pierce; Lori Shepherd; Martin Morgan; Rob Patro
Journal:  PLoS Comput Biol       Date:  2020-02-25       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.